Advertisement
Canada markets close in 5 hours 24 minutes

  • S&P/TSX

    21,946.85
    +61.47 (+0.28%)
     

  • S&P 500

    5,101.11
    +52.69 (+1.04%)
     

  • DOW

    38,270.30
    +184.50 (+0.48%)
     

  • CAD/USD

    0.7317
    -0.0006 (-0.08%)
     

  • CRUDE OIL

    83.69
    +0.12 (+0.14%)
     

  • Bitcoin CAD

    88,075.98
    +1,334.54 (+1.54%)
     

  • CMC Crypto 200

    1,344.84
    -51.69 (-3.70%)
     

  • GOLD FUTURES

    2,350.90
    +8.40 (+0.36%)
     

  • RUSSELL 2000

    2,001.13
    +20.01 (+1.01%)
     

  • 10-Yr Bond

    4.6460
    -0.0600 (-1.27%)
     

  • NASDAQ

    15,907.63
    +295.87 (+1.90%)
     

  • VOLATILITY

    15.27
    -0.10 (-0.65%)
     

  • FTSE

    8,139.06
    +60.20 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6841
    +0.0020 (+0.29%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

CSE New Listing - Trulieve Cannabis Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile Corp.
Updated

Vancouver, British Columbia--(Newsfile Corp. - September 27, 2018) - Trulieve Cannabis Corp. (CSE: TRUL) is the latest new listing on the Canadian Securities Exchange, following a RTO with Schyan Exploration Inc., a reporting issuer in the Province of Ontario. Trulieve US is the first and largest fully-licensed medical cannabis company in the state of Florida and serves over 80,000 patients.

InvestmentPitch Media has produced a "video" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Trulieve" in the search box.



Cannot view this video? Visit:
https://www.youtube.com/watch?v=0ndVP-4TXBs

ADVERTISEMENT

It is completely, vertically integrated with over 450,000 square feet of cultivation facilities with a further 95,000 square feet to be added in 2018. The company operates a certified processing facility that produces 90 different private label, medical grade cannabis products that are sold through 17 company-owned dispensaries.

Kim Rivers, CEO, stated: "Trulieve US was built with a patients-first mentality by focusing on improving access to medical cannabis while producing the highest quality products in the industry. Achieving this important milestone of a public listing enhances our ability to expand and serve more patients while allowing investors to participate in our growth."

The company recently released its financials for the quarter ending June 30, 2018. The company ended the quarter with 16 operating dispensaries serving 83,000 active patients.

Revenue grew from US$15.2 million in the quarter ended March 31, 2018 to US$23.3 million for the quarter ended June 30, 2018. EBITDA increased from US$11.2 million in the quarter ended March 31, 2018 to US$14.3 million for the quarter ended June 30, 2018.

Kim Rivers, CEO, further commented: "The second quarter of 2018 demonstrated our ability to scale our business profitably with growth in dispensaries and patients served driving growth in revenue and EBITDA. This momentum is continuing in the current quarter and we expect strong results throughout 2018."

For more information, please visit the company's website at www.trulieve.com, contact Kevin Darmody, Director of Investor Relations, at 850-480-7955 or email IR@trulieve.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com